Frank arrives at the Cleveland-based materials company with a three-decade track record in agricultural chemicals and global operations. His tenure at UPL and a 25-year career at Monsanto were marked by a focus on commercializing new technologies and driving profitability across diverse international markets. According to Fearon, the board expects Frank’s operational discipline to accelerate the market adoption of Avient’s product pipeline and bolster margin expansion.

Dr. Khandpur will remain with the company in an advisory capacity through the end of 2026 to ensure a smooth transition. Under his leadership, the company repositioned its strategy and upgraded research and development efforts. Alongside the leadership change, Avient reaffirmed its financial guidance for the third quarter and the full year of 2026, with earnings results scheduled for release on November 4.